Head and neck cancers, Nasopharyngeal cancer, Pharyngeal cancer
Results
Phase 1
This trial looked at a vaccine that might help the immune system to recognise and kill nasopharyngeal cancer cells that contained a virus called Epstein Barr.
Nasopharyngeal cancer is a cancer that begins in the part of your throat called the nasopharynx.
Cancer Research UK supported this trial.
Recruitment start: 1 June 2013
Recruitment end: 10 March 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Neil Steven
Cancer Research UK (Centre for Drug Development)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/13/001.
Last reviewed: 17 May 2018
CRUK internal database number: 2563